A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma

PURPOSE: Standard care for unresectable locally advanced esophageal squamous cell carcinoma (ESCC) is concurrent chemoradiotherapy, but survival remains limited. Neoadjuvant chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) has demonstrated promising activity, with a pathological complet...

Descripción completa

Detalles Bibliográficos
Autores principales: Satake, Hironaga, Tahara, Makoto, Mochizuki, Satoshi, Kato, Ken, Hara, Hiroki, Yokota, Tomoya, Kiyota, Naomi, Kii, Takayuki, Chin, Keisho, Zenda, Sadamoto, Kojima, Takashi, Bando, Hideaki, Yamazaki, Tomoko, Iwasa, Satoru, Honma, Yoshitaka, Hamauchi, Satoru, Tsushima, Takahiro, Ohtsu, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921115/
https://www.ncbi.nlm.nih.gov/pubmed/27193097
http://dx.doi.org/10.1007/s00280-016-3062-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921115/
https://www.ncbi.nlm.nih.gov/pubmed/27193097
http://dx.doi.org/10.1007/s00280-016-3062-2

Ejemplares similares